It has been suggested that survival in babies with trisomy 18 may be b
etter than previously recognised, and that cardiac surgery may be just
ified. A population based study spanning seven years in one English he
alth region is presented. The fetal prevalence at 18 weeks was 1 in 42
74 and birth prevalence 1 in 8333 live births, Trisomy 18 was detected
antenatally in 43% of cases, but almost 90% of those born without a d
iagnosis were known to be growth retarded in utero. More than 50% of l
iveborn infants were delivered by caesarean section. The median surviv
al of those born alive was 3 days with no babies living longer than on
e year. Cardiac malformations were not universal but were present in m
ore than 87% of those for whom there were data. However, in only three
cases were cardiac problems implicated in the death of the infants. C
ardiac surgery is not likely to improve the survival of infants with t
risomy 18 and at present cannot be justified. The most common mode of
death was central apnoea.